150 related articles for article (PubMed ID: 24137228)
1. Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy.
He H; Qiao X; Wu S
Exp Ther Med; 2013 Aug; 6(2):567-573. PubMed ID: 24137228
[TBL] [Abstract][Full Text] [Related]
2. CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways.
Hooshmandi E; Moosavi M; Katinger H; Sardab S; Ghasemi R; Maghsoudi N
Mol Biol Rep; 2020 Mar; 47(3):2097-2108. PubMed ID: 32067159
[TBL] [Abstract][Full Text] [Related]
3. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
[TBL] [Abstract][Full Text] [Related]
4. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.
Moosavi M; Hooshmandi E; Javadpour P; Maghsoudi N; Katinger H; Ghasemi R
Behav Brain Res; 2020 Apr; 384():112554. PubMed ID: 32057828
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Human Erythropoietin Protects Myocardial Cells from Apoptosis via the Janus-Activated Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway in Rats with Epilepsy.
Ma BX; Li J; Li H; Wu SS
Curr Ther Res Clin Exp; 2015 Dec; 77():90-8. PubMed ID: 26649078
[TBL] [Abstract][Full Text] [Related]
6. Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/AKT signaling.
Na N; Zhao D; Zhang J; Wu J; Miao B; Li H; Luo Y; Tang Z; Zhang W; Bellanti JA; Zheng SG
Signal Transduct Target Ther; 2020 Sep; 5(1):194. PubMed ID: 32934199
[TBL] [Abstract][Full Text] [Related]
7. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
[TBL] [Abstract][Full Text] [Related]
8. Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis.
Abe T; Isaka Y; Imamura R; Kakuta Y; Okumi M; Yazawa K; Ichimaru N; Tsuda H; Nonomura N; Takahara S; Okuyama A
Cell Transplant; 2012; 21(2-3):571-80. PubMed ID: 22410315
[TBL] [Abstract][Full Text] [Related]
9. Baicalein Protects Rats with Diabetic Cardiomyopathy Against Oxidative Stress and Inflammation Injury via Phosphatidylinositol 3-Kinase (PI3K)/AKT Pathway.
Ma L; Li XP; Ji HS; Liu YF; Li EZ
Med Sci Monit; 2018 Aug; 24():5368-5375. PubMed ID: 30070262
[TBL] [Abstract][Full Text] [Related]
10. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
[TBL] [Abstract][Full Text] [Related]
11. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
Adembri C; Massagrande A; Tani A; Miranda M; Margheri M; De Gaudio R; Pellegrini-Giampietro DE
Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
[TBL] [Abstract][Full Text] [Related]
12. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin and Its Derivates Modulate Mitochondrial Dysfunction after Diffuse Traumatic Brain Injury.
Millet A; Bouzat P; Trouve-Buisson T; Batandier C; Pernet-Gallay K; Gaide-Chevronnay L; Barbier EL; Debillon T; Fontaine E; Payen JF
J Neurotrauma; 2016 Sep; 33(17):1625-33. PubMed ID: 26530102
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
[TBL] [Abstract][Full Text] [Related]
16. Carbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesis.
Imamura R; Isaka Y; Ichimaru N; Takahara S; Okuyama A
Biochem Biophys Res Commun; 2007 Feb; 353(3):786-92. PubMed ID: 17196938
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties.
Moon C; Krawczyk M; Paik D; Coleman T; Brines M; Juhaszova M; Sollott SJ; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2006 Mar; 316(3):999-1005. PubMed ID: 16306273
[TBL] [Abstract][Full Text] [Related]
18. Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury.
Simon F; Scheuerle A; Gröger M; Vcelar B; McCook O; Möller P; Georgieff M; Calzia E; Radermacher P; Schelzig H
Intensive Care Med; 2011 Sep; 37(9):1525-33. PubMed ID: 21779851
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.
Ding J; Wang J; Li QY; Yu JZ; Ma CG; Wang X; Lu CZ; Xiao BG
Mol Neurobiol; 2017 Sep; 54(7):5051-5060. PubMed ID: 27541284
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-targeted semaglutide-loaded PEG-nanoliposomes microbubble destruction protects diabetic cardiomyopathy by activating PI3K/Akt/Nrf2 signaling pathway.
Zhu J; Wang H; Yan C; Li B; Chen B
Heliyon; 2023 Sep; 9(9):e19873. PubMed ID: 37809373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
